A Clinical Trial to Evaluate the Food Effect on Pharmacokinetic Profiles and Safety of CKD-379
Conditions: Type 2 Diabetes Mellitus Interventions: Drug: CKD-379(Empagliflozin+sitagliptin+metformin) Test drug; Drug: CKD-379(Empagliflozin+sitagliptin+metformin) Reference drug Sponsors: Chong Kun Dang Pharmaceutical Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Clinical Trials | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Empagliflozin | Endocrinology | Fortamet | Janumet | Januvia | Jardiance | Metformin | Research